American Journal of Kidney Diseases

Bleeding Complications After Transcutaneous Kidney Biopsy in Patients With Systemic Amyloidosis: Single-Center Experience in 101 Patients


      Bleeding is one of the most common complications after kidney biopsy. Amyloidosis is thought to be 1 of the risk factors, but this has not been confirmed in a large study. We performed this study to assess the risk of bleeding after kidney biopsy in patients with amyloidosis.

      Study Design

      Retrospective study.

      Settings & Participants

      101 patients with and 188 patients without amyloidosis undergoing outpatient percutaneous kidney biopsy at a major medical center in the absence of abnormal partial thromboplastin time, prothrombin time international normalized ratio, or platelet count and/or uncontrolled hypertension.


      Clinical diagnosis of amyloidosis.

      Outcomes & Measurements

      Post–kidney biopsy bleeding confirmed by means of imaging. Bleeding was defined as major if it required blood transfusion, hospital admission, or other invasive procedures and minor if none of these interventions were needed.


      Post–kidney biopsy bleeding was observed in 9.9% of patients with amyloidosis and 10.6% of controls (P = 0.8). Bleeding was major in 4% of patients with amyloidosis and 2.1% of controls (P = 0.4). Three patients from each group required blood transfusions and selective renal angiography. All except 1 patient from the control group underwent embolization.


      Retrospective data analysis and overall low event rate did not allow for independent risk-factor analysis.


      The present study suggests that in the absence of a hematostatic disorder and/or uncontrolled hypertension, bleeding risk during kidney biopsy is not increased in patients with systemic amyloidosis. Kidney biopsy can be performed safely using the same screening criteria as for patients without amyloidosis.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Korbet S.M.
        Percutaneous renal biopsy.
        Semin Nephrol. 2002; 22: 254-267
        • Kovalik E.C.
        • Schwab S.J.
        • Gunnells J.C.
        • Bowie D.
        • Smith S.R.
        No change in complication rate using spring-loaded gun compared to traditional percutaneous renal allograft biopsy techniques.
        Clin Nephrol. 1996; 45: 383-385
        • Fraser I.R.
        • Fairley K.F.
        Renal biopsy as an outpatient procedure.
        Am J Kidney Dis. 1995; 25: 876-878
        • Parrish A.E.
        Complications of percutaneous renal biopsy: A review of 37 years' experience.
        Clin Nephrol. 1992; 38: 135-141
        • Prakash J.
        • Singh M.
        • Tripathi K.
        • Rai U.S.
        Complications of percutaneous renal biopsy.
        J Indian Med Assoc. 1994; 92: 395-396
        • Song J.H.
        • Cronan J.J.
        Percutaneous biopsy in diffuse renal disease: Comparison of 18- and 14-gauge automated biopsy devices.
        J Vasc Interv Radiol. 1998; 9: 651-655
        • Preda A.
        • Van Dijk L.C.
        • Van Oostaijen J.A.
        • Pattynama P.M.
        Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun.
        Eur Radiol. 2003; 13: 527-530
        • Whittier W.L.
        • Korbet S.M.
        Renal biopsy: Update.
        Curr Opin Nephrol Hypertens. 2004; 13: 661-665
        • Hergesell O.
        • Felten H.
        • Andrassy K.
        • Kuhn K.
        • Ritz E.
        Safety of ultrasound-guided percutaneous renal biopsy—Retrospective analysis of 1090 consecutive cases.
        Nephrol Dial Transplant. 1998; 13: 975-977
        • Manno C.
        • Strippoli G.F.
        • Arnesano L.
        • et al.
        Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy.
        Kidney Int. 2004; 66: 1570-1577
        • Eiro M.
        • Katoh T.
        • Watanabe T.
        Risk factors for bleeding complications in percutaneous renal biopsy.
        Clin Exp Nephrol. 2005; 9: 40-45
        • Palladini G.
        • Perfetti V.
        • Merlini G.
        Therapy and management of systemic AL (primary) amyloidosis.
        Swiss Med Wkly. 2006; 136: 715-720
        • Merlini G.
        • Bellotti V.
        Molecular mechanisms of amyloidosis.
        N Engl J Med. 2003; 349: 583-596
        • Bergesio F.
        • Ciciani A.M.
        • Santostefano M.
        • et al.
        Renal involvement in systemic amyloidosis—An Italian retrospective study on epidemiological and clinical data at diagnosis.
        Nephrol Dial Transplant. 2007; 22: 1608-1618
        • Kyle R.A.
        • Gertz M.A.
        Primary systemic amyloidosis: Clinical and laboratory features in 474 cases.
        Semin Hematol. 1995; 32: 45-59
        • Pepys M.B.
        Pathogenesis, diagnosis and treatment of systemic amyloidosis.
        Philos Trans R Soc Lond B Biol Sci. 2001; 356 (discussion, 210-211): 203-210
        • Lachmann H.J.
        • Booth D.R.
        • Booth S.E.
        • et al.
        : Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
        N Engl J Med 346. 2002; 346 ([see comment]): 1786-1791
        • Yood R.A.
        • Skinner M.
        • Rubinow A.
        • Talarico L.
        • Cohen A.S.
        Bleeding manifestations in 100 patients with amyloidosis.
        JAMA. 1983; 249: 1322-1324
        • Mumford A.D.
        • O'Donnell J.
        • Gillmore J.D.
        • Manning R.A.
        • Hawkins P.N.
        • Laffan M.
        Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.
        Br J Haematol. 2000; 110: 454-460
        • Sucker C.
        • Hetzel G.R.
        • Grabensee B.
        • Stockschlaeder M.
        • Scharf R.E.
        Amyloidosis and bleeding: Pathophysiology, diagnosis, and therapy.
        Am J Kidney Dis. 2006; 47: 947-955
        • Choufani E.B.
        • Sanchorawala V.
        • Ernst T.
        • et al.
        Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations, and response to high-dose chemotherapy.
        Blood. 2001; 97: 1885-1887
        • Enjeti A.K.
        • Walsh M.
        • Seldon M.
        Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
        Haemophilia. 2005; 11: 535-538
        • Ralls P.W.
        • Barakos J.A.
        • Kaptein E.M.
        • et al.
        Renal biopsy-related hemorrhage: Frequency and comparison of CT and sonography.
        J Comput Assist Tomogr. 1987; 11: 1031-1034
        • Nicholson M.L.
        • Wheatley T.J.
        • Doughman T.M.
        • et al.
        A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy.
        Kidney Int. 2000; 58: 390-395
        • Gazelle G.S.
        • Haaga J.R.
        • Rowland D.Y.
        Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy.
        Radiology. 1992; 183: 509-513